The treatment of Qibai Pingfei Capsule on chronic obstructive pulmonary disease may be mediated by Th17/Treg balance and gut-lung axis microbiota
Y Jia, T He, D Wu, J Tong, J Zhu, Z Li… - Journal of Translational …, 2022 - Springer
Background Chronic obstructive pulmonary disease (COPD), a prevalent, progressive
respiratory disease, has become the third leading cause of death globally. Increasing …
respiratory disease, has become the third leading cause of death globally. Increasing …
Xuanbai Chengqi decoction ameliorates pulmonary inflammation via reshaping gut microbiota and rectifying Th17/Treg imbalance in a murine model of chronic …
Y Wang, N Li, Q Li, Z Liu, Y Li, J Kong… - … journal of chronic …, 2021 - Taylor & Francis
Purpose Chronic obstructive pulmonary disease (COPD), a prevalent obstructive airway
disease, has become the third most common cause of death globally. Xuanbai Chengqi …
disease, has become the third most common cause of death globally. Xuanbai Chengqi …
Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen …
P Zhao, J Li, Y Tian, J Mao, X Liu, S Feng, J Li… - Journal of …, 2018 - Elsevier
Abstract Ethnopharmacology relevance Bufei Yishen formula (BYF), a Traditional Chinese
Medicine (TCM), has been extensively applied in clinical treatment of chronic obstructive …
Medicine (TCM), has been extensively applied in clinical treatment of chronic obstructive …
The Bufei Jianpi formula improves mucosal immune function by remodeling gut microbiota through the SCFAs/GPR43/NLRP3 pathway in chronic obstructive …
J Mao, Y Li, Q Bian, Y Xuan, J Li, Z Wang… - … Journal of Chronic …, 2022 - Taylor & Francis
Purpose Bufei Jianpi formula (BJF), a traditional Chinese medicine, is an effective and safe
therapeutic formula for chronic obstructive pulmonary disease (COPD). BJF treatment is …
therapeutic formula for chronic obstructive pulmonary disease (COPD). BJF treatment is …
Systematic Pharmacology‐Based Strategy to Explore the Mechanism of Bufei Huoxue Capsule in the Treatment of Chronic Obstructive Pulmonary Disease
L Shi, J Yan, Y Meng, G Wang, J Du… - Evidence‐Based …, 2022 - Wiley Online Library
Objective. To explore the effects and mechanisms of Bufei Huoxue Capsule (BHC) on
chronic obstructive pulmonary disease (COPD) based on network pharmacology. Methods …
chronic obstructive pulmonary disease (COPD) based on network pharmacology. Methods …
Qi-Long-Tian capsule alleviates pulmonary fibrosis development by modulating inflammatory response and gut microbiota
Q Zhang, T Luo, D Yuan, J Liu, Y Fu, J Yuan - Functional & integrative …, 2023 - Springer
Pulmonary fibrosis (PF) is a chronic, progressive, and fibrotic interstitial lung disease with a
high mortality rate. Qi-Long-Tian (QLT) capsule is an herbal formula with great potential for …
high mortality rate. Qi-Long-Tian (QLT) capsule is an herbal formula with great potential for …
Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor
P Zhao, X Liu, H Dong, Y Tian, S Feng… - Frontiers in …, 2020 - frontiersin.org
Bufei Yishen formula (BYF) is a Traditional Chinese Medicine (TCM) reported to ameliorate
chronic obstructive pulmonary disease (COPD) by regulating the balance between T helper …
chronic obstructive pulmonary disease (COPD) by regulating the balance between T helper …
Gut Microbiota Protected Against pseudomonas aeruginosa Pneumonia via Restoring Treg/Th17 Balance and Metabolism
L Wen, L Shi, XL Kong, KY Li, H Li, DX Jiang… - Frontiers in cellular …, 2022 - frontiersin.org
Backgrounds and Purpose The theory of “entero-pulmonary axis” proves that pneumonia
leads to gut microbiota disturbance and Treg/Th17 immune imbalance. This study is aimed …
leads to gut microbiota disturbance and Treg/Th17 immune imbalance. This study is aimed …
Modified Bushen Yiqi Formula mitigates pulmonary inflammation and airway remodeling by inhibiting neutrophils chemotaxis and IL17 signaling pathway in rats with …
Q Kong, B Wang, Y Zhong, W Chen, J Sun, B Liu… - Journal of …, 2024 - Elsevier
Ethnopharmacological relevance Chronic obstructive pulmonary disease (COPD) is a major
global health concern characterized by pulmonary inflammation and airway remodeling …
global health concern characterized by pulmonary inflammation and airway remodeling …
Dissection of pharmacological mechanism of Chinese herbal medicine Yihuo huatan formula on chronic obstructive pulmonary disease: a systems pharmacology …
XW Zhang, W Liu, HL Jiang, B Mao - Scientific Reports, 2019 - nature.com
Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory
diseases. Yihuo Huatan Formula (YHF), as a proven Chinese Herbal Medicine (CHM), has …
diseases. Yihuo Huatan Formula (YHF), as a proven Chinese Herbal Medicine (CHM), has …